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S UMM A R Y
LUNG HEALTH ACROSS THE life course is influ-
enced by factors affecting airway and alveolar develop-
ment and growth during antenatal and perinatal periods,
throughout childhood and adolescence, and into adult-
hood. Lung function trajectories are set in early life and
childhood deficits may predispose to non-communicable
respiratory diseases, such as asthma and chronic
obstructive pulmonary disease, in later years. Potential
risk factors are common in many sub-Saharan African
(sSA) countries; adverse antenatal environments cause in
utero growth restriction and prematurity; HIV and
respiratory infections, including TB are common;
exposure to air pollution is widespread, including
household air pollution from biomass fuel use, traffic-
related pollution in rapidly expanding cities, and
tobacco smoke exposure. Multiple disadvantages expe-
rienced in early life require an integrated approach that
addresses reproductive, maternal and child health.
Public health strategies need to tackle multiple risk
factors, emphasising Universal Health Coverage, to
maximise lung health in the world’s poorest, most
vulnerable populations. This review explores potential
determinants of lung health across the life course. Due to
the extensive topic and wide range of related literature,
we prioritised more recent citations, especially those
from sSA, focusing on risk factors for which there is
most information, and which are most prevalent in the
region.
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LUNG GROWTH AND DEVELOPMENT in early
life impacts on adult lung health, and poverty-related
risk factors are commonly encountered across the
sub-Saharan African (sSA) region.1 In contrast to
high-income countries (HICs), the region bears a high
burden of communicable respiratory disease, includ-
ing childhood pneumonia, TB and HIV-related lung
infections.2-4 Non-communicable respiratory diseas-
es, such as asthma and chronic obstructive pulmonary
disease (COPD) are also increasingly prevalent in
sSA, placing a burden on overstretched health care
systems, which are poorly equipped to diagnose,
monitor and treat long-term conditions.5 Spirometry
data from the region have identified that both child
and adult lung volumes are decreased compared to
Caucasian reference ranges; the prognostic signifi-
cance of this finding is unclear and locally appropri-
ate reference ranges, representing maximal lung
growth in the absence of adverse factors for sSA
populations are lacking.6–8
This review aims to highlight the issues which impact
on the lung health, including both non-communicable
and communicable respiratory diseases, of some of the
world’s poorest communities. We reviewed PubMed
referenced literature, published pre-December 2019,
with studies identified through combinations of MeSH
and key word searches for each topic, including
pregnancy, infant, child, adolescent, lung, lung func-
tion, pneumonia, nutrition, air pollution, smoke, TB,
HIV, and a search line relating to Africa or individually
named African countries, with subsequent cited
reference searching. Research originating from sSA
was prioritised, with a focus on risk factors most
relevant to the region, guided by the authors’ local
expertise. To provide context, we begin with a brief
overview of lung development and growth.
LUNG DEVELOPMENT AND GROWTH: IN
UTERO, THROUGH CHILDHOOD AND
ADOLESCENCE
Human foetal lung development occurs in five phases
(Table), with the formation of the conducting airways
and alveoli, essential components for effective ex
utero gas exchange, by the end of a full-term
pregnancy. By the start of the third trimester of
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pregnancy, airway branching is completed, the gas-
exchange region is developing and surfactant pro-
duction has begun. Subsequently, there is further
growth of the pulmonary parenchyma and matura-
tion of the surfactant system. From approximately 32
weeks’ gestation, there is rapid expansion of alveolar
numbers and resulting lung growth, which continues
postnatally during the first 2 years of life. Stereolog-
ical assessment of lungs from human autopsies and
studies using helium-3 magnetic resonance to assess
alveolar size suggest that neo-alveolarisation contin-
ues throughout childhood and adolescence.9,10 After
this point, alveolar size continues to increase with
somatic growth but alveolar numbers remain con-
stant, at around 300–600 million.11 There is some
evidence that lung growth is possible in adulthood,
through expansion of alveolar numbers, under
specific circumstances (e.g., post-pneumonectomy).12
Although airway development is largely completed by
birth, airway growth, with increasing airway diam-
eter and length, continues to a plateau at 20–25 years
of age, with gradual decline thereafter.13
Timings are approximate and there is overlap
between developmental phases. Insults to the lungs
at any point across the life course have potential to
disrupt the normal stages of growth and development
(Figure 1). Repair of damaged airways and patho-
logical remodelling can affect various airway ele-
ments, occurring even in early childhood: bronchial
reticular basement thickening has been identified in
children with severe pre-school wheeze.14 15
The early life origins of lung function and
respiratory disease have been established in several
longitudinal birth cohort studies, all conducted in
HIC.1 The Tucson Children’s Respiratory Study
described symptom patterns in early childhood and
subsequent respiratory morbidity; wheezing at age 6
years was associated with both chronic and new-
onset asthma in adulthood, and lung function deficits
present by age 6 years, persisted thereafter.16 Birth
cohort studies from New Zealand and Australia, also
reported tracking of lung function, with lung function
following centiles set in early childhood throughout
later childhood and adulthood, regardless of asthma
Table Phases of in utero lung development1
Phase (timing) Developmental processes
Embryonic phase (4–7 weeks’ gestation)  Lung buds develop
Pseudoglandular phase (7–16 weeks’ gestation)  Conductive airway pattern develops
 Early airway epithelium differentiation
Canalicular phase (17–26 weeks’ gestation)  Completion of airway branching
 Development of gas exchange region
Saccular phase (27–36 weeks’ gestation)  Growth and maturation of peripheral airways, differentiation
of alveolar epithelial cells and maturation of surfactant system
Alveolar phase (34 weeks’ gestation to adolescence)  Increase in alveolar number and subsequent increase in gas
exchange area
Figure 1 The impact of common risk factors encountered in sub-Saharan Africa on lung function trajectories across the life course.
Trajectories shown (not to scale) demonstrate possible impact of adverse factors acting in childhood (dotted), in utero and childhood
(dot-dash), in early adulthood (long dash) and later adulthood (long dash-dot-dot), compared to optimal lung growth (solid line). FEV1
¼ forced expiratory volume in 1 sec; TB¼ tuberculosis; LRTI¼ lower respiratory tract infection; HAP¼ household air pollution; ETS¼
environmental tobacco smoke.
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severity.17,18 The Drakenstein Child Health Study
(DCHS) in South Africa, will provide data of greater
relevance to populations in sSA, as this cohort
ages.19–21 Potential risk factors for adverse lung
health outcomes vary between high- and low-income
settings: risk factors of particular relevance to low-
and middle-income countries (LMICs) in sSA are
discussed in subsequent sections, divided into ante-
natal, perinatal, childhood and adulthood life stages.
MATERNAL EXPOSURE TO INHALED
POLLUTANTS DURING PREGNANCY:
TOBACCO SMOKE, HOUSEHOLD AND
AMBIENT AIR POLLUTION
There is strong evidence from HICs that in utero
exposure to tobacco smoke is associated with reduced
respiratory function in the early neonatal period, and
increased prevalence of respiratory infections and
asthma.22 The South African DCHS reported altered
lung function at age 6–10 weeks in infants of
maternal smokers, and increased wheeze and lower
respiratory tract infection (LRTI) at age 1 year.19,21
Nicotine exposure is thought to be a key mediator of
altered pulmonary function: this is not currently a
major problem in sSA, where rates of maternal
smoking are low, but impaired lung development
may also result from hypoxaemia secondary to
carbon monoxide (CO) exposure. High CO levels
are found in cigarette smokers and also in those using
biomass fuels to cook in low-income settings.7 The
effect of in utero household air pollution from
incomplete combustion of biomass fuels on foetal
lung development is largely unknown. Recent work
from Ghana described an association between in
utero household air pollution exposure and impaired
infant lung function at 30 days of age.23 In South
Africa, antenatal exposure to the volatile organic
compound toluene was associated with severe LRTI
in infants; further research on this kind of exposure in
early life is needed.21
A few studies from high-income settings have
explored the impact of air pollution exposure during
pregnancy, reporting associations between maternal
exposure to pollutants and altered lung function in
early infancy and at pre-school age.24 A population-
based nested case-control study reported an increased
risk of asthma diagnosis with increased exposure to
pollutants in utero and during the first year of life,
with the strongest effects noted for traffic-related air
pollutants.25
MATERNAL NUTRITION DURING PREGNANCY
Modification of maternal nutrition has been suggest-
ed as a potential strategy in the primary prevention of
asthma, with particular interest in maternal intake of
vitamins D, E and omega-3 polyunsaturated fatty
acids (PUFAs) during pregnancy.26 A large UK-based
birth cohort study reported a beneficial effect of
maternal zinc intake during pregnancy on lung
function at age 7–9 years but no effect on asthma
diagnosis, and found no association between other
antioxidants, including vitamin E, and asthma or
lung function.27 Although randomised controlled
trials (RCTs) from Denmark and United States
suggested that high dose vitamin D3 supplementation
during the second and third trimester of pregnancy
might protect against wheeze at age 3 years, but
neither trial found an effect on asthma diagnosis at
age 6 years.28,29
The COPSAC group also conducted an RCTof n-3
long-chain PUFA supplementation during the third
trimester of pregnancy. A 31% risk reduction for
persistent wheeze at age 3–5 years was seen in
children of mothers receiving supplementation, with
the greatest effect seen in mothers with the lowest
blood levels of long-chain PUFAs at randomisation.30
There has been no research to date on maternal
micronutrient status and respiratory outcomes in
LICs. Considering maternal nutritional intake more
broadly, maternal undernutrition and subsequent
foetal undernutrition leads to intrauterine growth
restriction (IUGR). The effects on lung structure
depend on the gestational timing and severity of
IUGR; potential mechanisms include impaired alveo-
larisation, thickening of inter-alveolar septa due to
increased extracellular matrix deposition, and thick-
ening of the alveolar blood-air barrier due to
increased basement membrane thickness.31
LOW BIRTH WEIGHT AND PREMATURITY
Low birth weight (LBW; defined as a birth weight of
,2500 g) may be due to IUGR, premature delivery
(before 37 weeks’ gestation) or both. Premature
delivery and IUGR are more common in LICs; in
sSA, approximately one in eight infants are born
early.32 Young maternal age and short inter-pregnan-
cy intervals are common risk factors contributing to
premature delivery and IUGR. Poor maternal nutri-
tion, intrauterine and systemic infection (e.g., malaria
and syphilis), and physical labour during pregnancy
may precipitate early labour, while low maternal
weight, hypertensive disorders of pregnancy, and
congenital infections (e.g., cytomegalovirus [CMV],
HIV, syphilis and malaria) are associated with
IUGR.33,34 Meta-analysis of studies from HICs found
a strong association between birth weight and adult
forced vital capacity (FVC); with 60 ml higher FVC in
adulthood per kg increase in birth weight (95%
confidence interval [CI] 43–76), but weaker evidence
for airflow obstruction.35
A recent meta-analysis of 11 studies conducted in
HICs found that infants born ,32 weeks’ gestation
or with a birth weight of ,1500 g had decreased
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airflow in late adolescence and early adulthood, with
a mean difference in forced expiratory volume in 1 sec
(FEV1) Z-score of –0.78 (95% CI –0.96 to –0.61)
compared to infants born at term or with normal
birthweight.36 The infants included in these studies
were born before the early 1990s, when surfactant
therapy was not available, as is currently the case in
many countries in sSA. However, there is increasing
availability and use of non-invasive continuous
positive airways pressure (CPAP) in LMIC hospi-
tals.37 With advances in neonatal care and improved
outcomes, increasing numbers of survivors may reach
adulthood with sub-maximal lung volumes and
airflow deficits.
EFFECT OF BREASTFEEDING ON LUNG HEALTH
Human breast milk contains many immunological
components, including antimicrobial, anti-inflamma-
tory and immunomodulatory agents.38 It is widely
accepted that breastfeeding reduces morbidity and
mortality related to LRTIs.38 A meta-analysis of 18
studies estimated that breastfeeding reduces the risk
of LRTI by 32%, LRTI-related hospital admissions
by 57% and LRTI-related deaths by 70%.39
However, the effect of breastfeeding on the
development of wheeze and asthma is less clear.
Results are conflicting, there is heterogeneity of
methodology and definitions used, and the ethical
problem of conducting RCTs with breastfeeding
mothers limits the quality of evidence available.
Human milk composition varies within and between
mothers, which may also explain conflicting data,
particularly relating to breastfeeding and the devel-
opment of allergic sensitisation and allergic disease.38
Furthermore, the research largely represents popula-
tions from HICs: a systematic review of 117 studies
included only one study from Africa and none from
LICs.40 The findings of this systematic review
suggested that breastfeeding protects against the
development of childhood asthma, with the strongest
association seen in children aged 0–2 years.40
Another meta-analysis reported decreased asthma at
age 5–18 years in breastfed children, with a greater
effect seen in LMICs; however, the quality of the
studies included was suboptimal.41 The International
Study of Asthma and Allergies in Childhood (ISAAC)
reported decreased non-atopic wheeze in children
who had been breastfed, with a stronger effect in
those from LMICs: adjusted odds ratio (aOR) 0.69
vs. 0.87 for LMICs and HICs, respectively.42 It seems
likely that the major effect of breastfeeding is on viral-
induced wheezing, rather than atopic wheeze. In
addition, the reduction in early life respiratory
infections associated with breastfeeding may reduce
the subsequent development of asthma.41
MALNUTRITION DURING CHILDHOOD
The recent ChroSAM study from Malawi found that
survivors of severe acute malnutrition (SAM) during
early childhood had comparable lung function to
control groups (siblings and community controls) at
7-years post-treatment; however 46% of the SAM
cases had died before follow-up: these children are
likely to have had more severe disease and possibly
poorer lung function had they survived.43 Stunting of
somatic growth, with preserved torso height and
shorter legs, is seen in survivors of malnutrition and
might suggest that lung function could also be
preserved.
A cross-sectional study of school-aged children
from Angola, Democratic Republic of Congo and
Madagascar found reduced FEV1 and FVC Z-scores,
but normal FEV1/FVC ratios, comparing undernour-
ished (body mass index Z-score ,–2) to normally
grown children, suggesting decreased lung growth
without evidence of airway obstruction.44
EXPOSURE TO INHALED POLLUTANTS DURING
CHILDHOOD: TOBACCO SMOKE, HOUSEHOLD
AND AMBIENT AIR POLLUTION
Over 90% of the world’s population breathe air that
fails to meetWHOAir Quality Guidelines, with those
from least developed countries worst affected.45
Inhaled pollutants come from various sources:
exposure levels depend on many factors, including
social habits, domestic fuel use, urbanisation, traffic
and transport, power plants and industry, policy and
legislation.
There is strong evidence from across the globe that
children exposed to tobacco smoke from either parent
have an increased risk of asthma.46 This risk is
greatest for children exposed to maternal smoking in
the first year of life, highlighting the importance of
exposures during early childhood.
Large cohort studies from high-income settings
following children in later childhood have explored
the impact of both regional air quality and local
traffic exposure on lung development. Diminished
lung function, most notably FEV1, was found in
children exposed to higher levels of air pollution
(particularly nitrogen dioxide [NO2], particulate
matter ,2.5 lm [PM2.5], acid vapour and elemental
carbon), and conversely, long-term improvements in
air quality have been associated with positive effects
on lung function growth in older children.47
Although it is well established that outdoor air
pollution contributes to exacerbations of pre-existing
asthma, the association with new-onset asthma is less
clear.48 There is accumulating evidence that ambient
air pollution, particularly traffic-related, is associated
with incident asthma in children.25,49 However, a
meta-analysis of cross-sectional studies comparing
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communities with different air pollution levels found
no effect of long-term exposure to pollution on
asthma diagnoses at community level.50
Research has tended to focus on individual
pollutants, reflecting air quality regulation method-
ology. However, the health effects of the pollutant
mixture may be more relevant.48 Traffic-related air
pollution (TRAP) is a complex pollution mixture
containing particulate matter (PM) and primary
gaseous emissions, including nitrogen oxides; these
emissions generate secondary pollutants such as
ozone, nitrates and organic aerosols. Health risks
are greatest for those living nearest to roadways,
particularly roads carrying heavy vehicles.51
Exposure to household air pollution (HAP) is a
major concern in LMICs, where the use of ineffi-
ciently burned, highly polluting biomass fuel is
common. Incomplete combustion using traditional
‘‘open-fire’’ cooking methods produces high levels of
pollutants such as CO and PM.52
Exposure to solid fuel use assessed using question-
naires and interviews is associated with increased
pneumonia risk in children aged ,5 years.53 How-
ever, the few studies that assessed exposure through
objective measurements of CO and PM2.5 have not
confirmed this association, raising the possibility that
this association is at least partly explained by
confounding by other poverty-related exposures.54
The effect of HAP on wheezing and asthma is
unclear. ISAAC reported an association between the
use of open fires for cooking and increased wheeze
(OR 2.17, 95% CI 1.64–2.87).55 However, a
previously published meta-analysis of four small
asthma studies in children exposed to biomass fuels
was inconclusive, reporting a pooled OR of 0.5 (95%
CI 0.12–1.98).53 Young children are susceptible to
high concentrations of particle deposition in lung
tissue due to physiological and anatomical factors.56
Environmental exposures, including inhaled pollut-
ants, during critical periods of lung growth and
development may lead to irreversible long-term
deficits in adult lung function.57
RESPIRATORY INFECTIONS IN EARLY LIFE
The importance of childhood respiratory infections
on mortality in childhood and adult lung function is
well recognised.2,58 Acute respiratory infections are
the leading cause of death in children aged ,5 years
worldwide, and may lead to long-term sequelae in
survivors, particularly in populations with significant
comorbidity, such as HIV and malnutrition.2,59 A
meta-analysis evaluating long-term pneumonia out-
comes in children under 5 years reported the risk of
serious sequelae (e.g., restrictive or obstructive lung
disease, bronchiectasis) at respectively 13.6% and
5.5% in hospitalised and non-hospitalised children,
with the highest risk in children from Africa.60
Wheezing illnesses in infancy due to respiratory
syncytial virus (RSV) and rhinovirus (RV) are
associated with increased risk of childhood asthma
in later childhood.61 Adenovirus infection is associ-
ated with the highest rates of long-term sequelae,
including development of bronchiolitis obliterans in
LMICs.60,62 Globally, RSV is the most common cause
of childhood respiratory infection, with the highest
incidence seen in LICs.63
Children from a high-risk birth cohort (with
parental allergy or asthma) showed an increased risk
of asthma at age 6 years, following wheezing RSVand
RV infections in the first 3 years of life (OR 2.6, 9.8
and 10.0 with respectively RSV, RV, and RSV/RV co-
infection); this increased asthma risk persisted at age
13 years following early life RV infection (OR 3.3)
but not RSV infection.64
The Tucson Children’s Respiratory Study Group
reported an increased prevalence of wheeze until age
11, following relatively mild RSV LRTI during the
first 3 years of life, although by age 13 years this risk
was no longer significant.65 In contrast, children with
severe RSV LRTI in the first year of life demonstrated
increased rates of allergic asthma and decreased lung
function compared to controls at age 18 years.66
The question remains as to whether respiratory
virus infections in early life are a causal factor in the
development of asthma, or whether the association
represents a vulnerability to viral infections in
children with pre-existing airway abnormalities.67
The DCHS identified LRTI as an independent risk
factor for reduced lung function at age 1 year,
independent of baseline lung function.20 There are
biologically plausible mechanisms for a causal
relationship: inflammatory mediators induced by
viral infection in early life may alter adaptive and
innate immune responses, leading to remodelling of
the developing alveoli and airways.68
HIV-infected children are at increased risk of
infection from common childhood respiratory path-
ogens (viral and bacterial), and opportunistic patho-
gens such as Pneumocystis jirovecii, CMV and
Mycobacterium tuberculosis.59 Adolescents from
sSA with perinatally acquired HIV infection have
high rates of chronic respiratory symptoms, abnor-
mal spirometry and chest radiographic abnormalities,
with increased burden among those with delayed
diagnosis.69 HIV-exposed, non-infected children
show altered lung function in early life, with greatest
risk for children of mothers with more severe
disease.70
Both immunocompetent and HIV-infected children
are at risk of TB infection in high-burden countries.3
Late diagnosis or inadequate treatment, may lead to
long-term lung complications, including scarring and
bronchiectasis.59
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EXPOSURE TO INHALED POLLUTANTS IN
ADULTHOOD: TOBACCO SMOKE,
HOUSEHOLD AIR POLLUTION AND
OCCUPATIONAL EXPOSURES
The detrimental effect of active tobacco smoking has
been long established, with longitudinal studies
documenting accelerated decline in FEV1 among
smokers compared to non-smokers.71 Active smoking
during adolescence impairs lung growth, indicating
that lung function in young adults starts to decline
from a lower peak FEV1.72
Accelerated FEV1 decline is one route by which
patients may reach a lung function threshold in
keeping with COPD; as discussed previously, im-
paired lung function in earlier life may lead to a lower
peak FEV1 in adulthood and COPD may occur with
‘‘normal’’ rates of age-related FEV1 decline.73 Recent
data from six US population-based cohorts reported
FEV1 decline at the median age (57 years) of 31.0 ml/
year in never smokers, 35.0 ml/year in former
smokers and 39.9 ml/year in current smokers,
suggesting that the ongoing process of progressive
lung damage continues even after smoking cessa-
tion.74 Of particular relevance to sSA, active smokers
are at increased risk of TB infection, with potential
long-term respiratory sequelae.75 Compared to high-
income settings, the incidence of lung cancer is
relatively low in sSA, although data are unreliable
due to challenges in diagnosis and reporting; tobacco
smoking is an important risk factor and explains the
higher burden of lung cancer reported in men
throughout the region.76
The effects of HAP on adult lung health are likely to
be most pronounced among women due to greater
involvement in domestic activities, including daily
cooking.77 Studies have demonstrated increased respi-
ratory symptoms (cough and sputum production),
chronic bronchitis and obstructive airways disease
among women who cook with biomass fuels.53 The
WHO identifies HAP arising from solid fuel use for
cooking, as a major risk factor for COPD world-
wide.77However, the studies informing this conclusion
have largely included self-reported biomass fuel use,
rather than objective measurement of pollution and
heterogeneous outcome variables, rarely including
post-bronchodilator spirometry to diagnose COPD.
Recent meta-analyses report conflicting results—a
meta-analysis of 25 BOLD (Burden of Obstructive
Lung Disease) study sites found no association
between airflow obstruction and self-reported use of
solid fuels for cooking or heating in LMICs and HICs,
while a pooled analysis from 13 LMIC sites reported
increased COPD in those with self-reported HAP
exposure (aOR 1.41, 95% CI 1.18–1.68].78,79 The
challenges in relying on self-reported exposure data,
which is subject to recall bias and misclassification,
and inadequate adjustment for confounding factors
are potential explanations for the conflicting results;
furthermore, all included data were from cross-
sectional surveys and therefore suboptimal for assess-
ing a causal relationship. Intervention studies aiming
to reduce HAP exposure and improve respiratory
outcomes for adults have also yielded inconclusive
results.80 Recent studies from rural Malawi suggest
that natural age-related lung function decline is not
accelerated by exposure to biomass smoke, and that
lung function deficits in adults are similar to those seen
in children from the same communities, highlighting
the importance of early life influences on lung growth
and development.7,8
Occupational lung disease is a considerable prob-
lem among miners (of gold, platinum and diamonds)
in mineral-rich sSA countries.81 Inhalation of silica
dust by South African gold miners causes inflamma-
tion and irreversible nodular fibrosis of the lungs
known as silicosis, with lung function decline
proportional to the degree of pulmonary changes.82
As strong risk factors for pulmonary TB, silica dust
exposure and silicosis have additional negative
impacts on lung health.81
HUMAN IMMUNODEFICIENCY VIRUS AND
TUBERCULOSIS IN ADULTHOOD
Despite advances in screening and access to treat-
ment, sSA continues to face the greatest global burden
of both HIV and TB infection.3,4 In sSA in 2017, an
estimated 723 000 people were diagnosed with new
HIV infection and 712 000 people died from HIV.4
Many HIV-infected people living in LMIC experience
serious or fatal lung complications; impaired host
defences increase the frequency and severity of
bacterial, mycobacterial, fungal, viral and parasite
infections. Furthermore, non-infectious lung disor-
ders—lung cancer, pulmonary arterial hypertension
and COPD—are more common in HIV-infected
individuals.83 Among those living with HIV/AIDS,
TB is the major cause of mortality worldwide.83
However, although HIV and TB are common co-
infections in sSA, the majority of new TB cases and
deaths worldwide occurred in HIV-negative individ-
uals in 2016.3
TB is associated with considerable morbidity, with
increasing recognition of the long-term consequences
of infection. Up to half of TB survivors have
persistent respiratory dysfunction despite microbio-
logical cure, with a wide range of structural
abnormalities and consequent symptoms.84 Cavita-
tion, bronchiectasis and fibrosis are the main features
seen on chest X-ray, and nodules, consolidation and
emphysema on computed tomography imaging.85
Resulting lung function impairment may include both
obstructive and restrictive patterns, with increasing
evidence that TB plays a role in the development of
COPD.84
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EMERGING THREATS
Research from HICs suggests that obesity increases
an individual’s risk of developing asthma and may
lead to more severe disease and resistance to asthma
treatment.86 Although previously considered a prob-
lem in HICs, childhood obesity is now a growing
concern across the globe, including LMICs.87 Child-
hood obesity rates are generally low in sSA; however,
southern Africa had the largest proportional rise in
obesity among 5–19-year olds between 1975 and
2016 globally.87 In southern Africa, 13.7% children
under 5 years are overweight, compared to ,5% in
eastern, middle and west Africa.88 This increasing
public health problem is likely to have a major impact
on the prevalence of non-communicable diseases,
including chronic respiratory conditions, across sSA.
Further research is needed to explore obesity preven-
tion interventions in LMICs to impact on dietary
behaviours and physical activity levels.88
Another emerging global public health concern is
the use of electronic cigarettes (e-cigarettes), partic-
ularly among young people. Lack of long-term safety
data means that the effect of chronic exposure to e-
cigarette emissions, containing nicotine, volatile
carbonyls, reactive oxygen species, furans and metals
on respiratory health is unknown.89 However,
increased respiratory symptoms are recognised
among adolescent e-cigarette users and proteomic
studies suggest that chronic vaping exerts biological
effects on the pulmonary epithelia, which may have
long-term consequences.90,91As discussed earlier, in
utero exposure to nicotine may adversely affect lung
development, and maternal e-cigarette use in preg-
nancy is therefore worrying. At present e-cigarette use
is low in sSA; data from the 2016 South African
Demographic Health Survey reported the prevalence
of e-cigarette use as respectively 2% and 3% in
women and men, compared to cigarette smoking
rates of 7% and 36%.
The global impact of the COVID-19 pandemic has
highlighted the fragility of overstretched health care
systems, particularly in LMICs where even basic
medical supplies and equipment are lacking. The
long-term respiratory effects of novel pathogens, such
as coronavirus SARS-CoV-2, are unknown. Longitu-
dinal study of cohorts of infected individuals from
diverse populations across the world, with differing
co-existing risk factors, would be helpful here.92
LOOKING AHEAD
In health care systems which are already under-
resourced and overburdened, policy makers must
focus their efforts on public health strategies which
are likely to have the maximum impact. Approaches
optimising lung development in utero and early
childhood have potential to show the greatest
cumulative effect; improved antenatal care will
promote foetal and neonatal lung health by reducing
rates of prematurity, IUGR and vertical HIV trans-
mission, and stronger postnatal support networks
Figure 2 Risk factors for poor lung health in sub-Saharan Africa and potential interventions. SDG¼Sustainable Development Goal;
HAP ¼ household air pollution; TRAP ¼ traffic-related air pollution; ETS ¼ environmental tobacco smoke; HIV ¼ human
immunodeficiency virus; PMTCT¼prevention of mother-to-child transmission; IUGR¼ intrauterine growth restriction; WASH¼water,
sanitation and hygiene; TB¼ tuberculosis.
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should promote exclusive breastfeeding, immunisa-
tion and improved hygiene practices to prevent early
life respiratory infections (Figure 2).30,38,39 Careful
consideration of the mother-infant dyad is essential;
factors affecting all aspects of maternal health—
physical, mental and social—may impact the health
of their child.
Beyond early childhood, prevention, screening and
early diagnosis, and appropriate treatment of respi-
ratory infections, HIV and TB are critical and need
strengthening in poorly resourced settings.59 Clean
air interventions have the potential to benefit lung
health across the life course and should be multi-
sectoral, considering diverse pollution sources, and
most importantly, supported by policy and legisla-
tion.52,77
By investing in integrative approaches which act
across reproductive, maternal and child health and
emphasise health education, promotion and disease
prevention, we have the opportunity to improve lung
health in the world’s poorest populations and enable
progress towards the achievement of Universal
Health Coverage and many of the United Nations
Sustainable Development Goals.
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R E´ S U M E´
La sante´ pulmonaire est influence´e tout au long de la vie
par des facteurs affectant le de´veloppement des voies
ae´riennes et des alve´oles et la croissance pendant les
pe´riodes ante´natales et pe´rinatales, tout au long de
l’enfance et de l’adolescence et pendant la vie adulte. Les
trajectoires de la fonction pulmonaire sont e´tablies au
de´but de la vie et des de´ficits dans l’enfance peuvent
pre´disposer a` des maladies respiratoires non
transmissibles comme l’asthme et les
bronchopneumopathies chroniques obstructives par la
suite. Les facteurs de risque potentiels sont fre´quents
dans de nombreux pays d’Afrique sub-Saharienne ; un
environnement ante´natal de´favorable cause un retard de
croissance in utero et une pre´maturite´ ; le VIH et les
infections respiratoires, dont la tuberculose, sont
fre´quentes ; l’exposition a` la pollution de l’air est
re´pandue, notamment celle des foyers en raison de
l’utilisation de la biomasse comme combustible, ainsi
que la pollution lie´e a` la circulation automobile dans des
villes qui s’agrandissent rapidement et enfin l’exposition
a` la fume´e de tabac. De multiples pre´judices, ve´cus au
de´but de la vie, requie`rent une approche inte´gre´e
comprenant la sante´ reproductive, maternelle et
enfantine. Les strate´gies de sante´ publique doivent
s’attaquer a` de multiples facteurs de risque, mettant
l’accent sur la couverture sante´ universelle, pour
maximiser la sante´ respiratoire dans les populations les
plus pauvres et vulne´rables du monde. Cette revue
explore les de´terminants potentiels de la sante´
pulmonaire tout au long de la vie. En raison de
l’ampleur du sujet et de la vaste litte´rature existante,
nous avons priorise´ les citations les plus re´centes, surtout
celles e´manant d’Afrique sub-Saharienne, en nous
focalisant sur les facteurs de risque pour lesquels on
dispose du maximum d’information et qui sont les plus
pre´valents dans la re´gion.
R E S UM E N
La salud respiratoria a lo largo del ciclo de la vida esta´
determinada por factores que interfieren con el
desarrollo y el crecimiento de las vı´as ae´reas y los
alve´olos en el perı´odo prenatal y perinatal, durante la
toda la infancia, la adolescencia y hasta la edad adulta.
La trayectoria de la funcio´n pulmonar se define
temprano en la vida y las deficiencias durante la
infancia pueden predisponer a enfermedades
respiratorias no transmisibles como el asma o la
enfermedad pulmonar obstructiva cro´nica en los an˜os
futuros. Los factores de riesgo son comunes en muchos
paı´ses de A´frica subsahariana; los entornos prenatales
adversos provocan restriccio´n del crecimiento
intrauterino y prematuridad; la infeccio´n por el virus
de la inmunodeficiencia humana (VIH) y las infecciones
respiratorias como la tuberculosis son frecuentes; la
exposicio´n a la contaminacio´n ambiental es generalizada
e incluye la contaminacio´n de interiores por utilizacio´n
de combustibles de biomasa, la contaminacio´n asociada
con el tra´nsito en las ciudades de crecimiento ra´pido y la
exposicio´n al humo de tabaco. Las desventajas mu´ltiples
impuestas en etapas tempranas de la vida exigen un
enfoque integrado que aborde la salud reproductiva y
maternoinfantil. Es necesario que las estrategias de salud
pu´blica afronten los factores de riesgo mu´ltiples, con
hincapie´ en la cobertura universal de salud, a fin de
fomentar al ma´ximo la salud respiratoria de las
poblaciones ma´s pobres y vulnerables del mundo. En
la presente revisio´n se examinan los posibles
determinantes de la salud respiratoria a lo largo del
ciclo de la vida. Dada la extensio´n del tema y la gran
diversidad de las publicaciones pertinentes, se dio
prioridad a los artı´culos ma´s recientes, en especial a los
provenientes de A´frica subsahariana, con un intere´s
central en los factores de riesgo sobre los cuales existe
ma´s informacio´n y que predominan en la regio´n.
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